Close Menu

NEW YORK ─ October was another slow month for 510(k) clearances from the US Food and Drug Administration amid the ongoing coronavirus pandemic. During the month, the agency granted only a few clearances, according to its website.

Saluggia, Italy-based DiaSorin got the nod for its Liaison Testosterone xt chemiluminescence immunoassay running on the firm's Liaison XL analyzer to measure testosterone in serum and plasma.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.